Related Experiment Video
Updated: Feb 15, 2026

Establishment and Culture of Patient-Derived Breast Organoids
Published on: February 17, 2023
Patient navigation reduces time to care for patients with breast symptoms and abnormal screening mammograms
Elaine McKevitt1, Carol Dingee1, Rebecca Warburton1
1Department of Surgery, Providence Health Care, 3080 Prince Edward St, Vancouver, BC, V5T 3N4, Canada; Department of Surgery, The University of British Columbia, 950West 10th Ave, Vancouver, BC, V5Z 1M9, Canada.
Introduction:
Concern has been raised about delays for patients presenting with breast symptoms in Canada. Our objective was to determine if our Rapid Access Breast Clinic (RABC) improved care for patients presenting with breast symptoms compared to the traditional system (TS).
Methods:
A retrospective chart review tabulated demographic, surgical, pathology and radiologic information. Wait times to care were determined for patients presenting with symptomatic and screen detected breast problems.
Results:
Time from presentation to surgeon evaluation was shorter in the RABC group for patients with breast symptoms (81 vs 35 days, p < .0001) and abnormal screens (72 vs 40 days, p = .092). Cancer patients with abnormal screens had shorter wait times than patients with breast symptoms in the TS (47 vs 70 days, p = .036).
Conclusion:
Coordination of imaging and clinical care reduces wait times in patients with both abnormal screening mammograms and symptomatic breast presentations and should be expanded in our province.
More Related Videos
05:54Real-Time Dynamic Navigation System for the Precise Quad-Zygomatic Implant Placement in a Patient with a Severely Atrophic Maxilla
Published on: October 18, 2021
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Related Concept Videos
Patient-centered Care
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients
Abnormal Proliferation
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Pediatric Patients: Drug Excretion